What is Organicare?
OrganiCare operates at the intersection of consumer wellness and sustainable manufacturing. As a women-led enterprise, the company distinguishes itself through a rigorous commitment to natural ingredient sourcing, effectively challenging traditional pharmaceutical and personal care incumbents. By prioritizing transparency and efficacy, OrganiCare has carved out a significant niche within the competitive healthcare landscape, appealing to a demographic that increasingly demands ethical and health-conscious alternatives to synthetic formulations. Its market position is bolstered by a lean, agile operational model that allows for rapid product iteration and a deep connection with its core consumer base.
How much funding has Organicare raised?
Organicare has raised a total of $13.1M across 2 funding rounds:
Angel/Seed
$4.5M
Series A
$8.5M
Angel/Seed (2019): $4.6M, investors not publicly disclosed
Series A (2021): $8.5M led by Seraph Group
Key Investors in Organicare
Seraph Group
A venture capital firm specializing in early-stage and growth-stage investments, focusing on companies with high potential for market disruption and scalable business models.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Organicare?
With the successful closure of this major enterprise-level funding, OrganiCare is poised to transition from a high-growth startup to a dominant player in the natural wellness space. The strategic roadmap likely includes expanding its distribution channels, enhancing research and development capabilities to broaden its product portfolio, and strengthening its supply chain resilience. As the company scales, the focus will remain on maintaining the integrity of its natural ingredient standards while navigating the complexities of mass-market retail. This capital injection provides the necessary runway to solidify its brand equity and establish long-term dominance in the rapidly evolving healthcare market.
See full Organicare company page
